← Leaderboards
Nima Toosizadeh
University Of Arizona
$2,343,115
Attributed
$3,737,615
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $986K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,737,615 · 4
By mechanism
R01$2,896,224 · 2
R21$841,391 · 2
Top collaborators
- Martha Jane Mohler4 shared
- Janko Nikolich-Zugich3 shared
Most similar at University Of Arizona
Same institution · by research overlap
- Janko Nikolich-Zugich$55,130,377
- Siyang Cao$582,741
- Nam Y Lee$5,950,434
- Amy Hui-Jiun Tsang$151,500
- Lila Boz$174,012
Others in their field
Other Emerging Leaders on “Participant”
- Chanza Baytop · Westat, Inc.$271,217,917
- Douglas S. Hawkins · Children'S Hosp Of Philadelphia$157,315,120
- Beth Baseler · Leidos Biomedical Research, Inc.$117,364,154
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$102,389,765
- Scott Topper · Broad Institute, Inc.$101,052,360
- Paul F Gallagher · Woods Hole Oceanographic Institution$92,619,872
Research focus
ParticipantResponseSensorFrailtyUpper ExtremitySamplingElderlyCognitiveMotorAdultElbowComorbidityCostAgingMultimodalityPerformanceLeadImpairmentFutureLegal PatentBedsArizonaCardiacMotion
Grant awards (10)
The role of CMV in HIV-associated accentuated aging$628,547
R01 · FY2025 · AG
Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease$308,644
R01 · FY2025 · AG · contact PI
The role of CMV in HIV-associated accentuated aging$646,602
R01 · FY2024 · AG
Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease$339,447
R01 · FY2024 · AG · contact PI
The role of CMV in HIV-associated accentuated aging$672,461
R01 · FY2023 · AG
Heart Rate Dynamics in Response to Upper-Extremity Function Test to Identify Irreversible Frailty After Invasive Therapy in Older Adults with Advanced Heart Disease$300,523
R01 · FY2023 · AG · contact PI
Functional Capacity Assessment in Hospitalized Bed-bound COPD Patients; Predicting Outcomes$191,875
R21 · FY2020 · AG · contact PI
Functional Capacity Assessment in Hospitalized Bed-bound COPD Patients; Predicting Outcomes$218,579
R21 · FY2019 · AG · contact PI
MCI and Alzheimer's Disease Screening using Upper-extremity Dual-task$193,858
R21 · FY2018 · AG · contact PI
MCI and Alzheimer's Disease Screening using Upper-extremity Dual-task$237,079
R21 · FY2017 · AG · contact PI